Sun Pharmaceutical subsidiary acquires Alchemee business from Galderma
Sun Pharmaceutical Industries said that its subsidiary Taro Pharmaceutical Industries’ fully-owned subsidiary Taro Pharmaceuticals U.S.A., has acquired Delaware-based Galderma Holdings, Japan-based Proactiv YK, Canada-based The Proactiv Company, and other assets of The Proactiv Company Sari. The consideration for the deal is $99.28 million. Galderma Holdings, which is incorporated in Delaware, Proactiv YK, The Proactiv Company, […]